CRP and hyperlipidemia: These statins are commonly prescribed as cholesterol-lowering agents in patients with hyperlipidemia and are considered to exert anti-inflammatory activity, as indicated by reduced levels of the inflammatory marker C-reactive protein in patients who are prescribed statins (Ridker et al., 2008).